References
- Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24–35.
- Rampias T, Sasaki C, Weinberger P, et al. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells. J Natl Cancer Inst. 2009;101:412–423.
- Klaes R, Friedrich T, Spitkovsky D, et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001;92:276–284.
- Chen ZW, Weinreb I, Kamel-Reid S, et al. Equivocal p16 immunostaining in squamous cell carcinoma of the head and neck: staining patterns are suggestive of HPV status. Head Neck Pathol. 2012;6:422–429.
- Kreimer AR, Clifford GM, Boyle P, et al. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14:467–475.
- Vageli D, Sourvinos G, Ioannou M, et al. High-risk human papillomavirus (HPV) in parotid lesions. Int J Biol Markers 2007;22:239–244.
- Brunner M, Koperek O, Wrba F, et al. HPV infection and p16 expression in carcinomas of the minor salivary glands. Eur Arch Otorhinolaryngol. 2012;269(10):2265–2269.
- Huhns M, Simm G, Erbersdobler A, et al. HPV Infection, but Not EBV or HHV-8 infection, is associated with salivary gland tumours. Biomed Res Int. 2015;2015:829349.
- Lin FC, Chen PL, Tsao TY, et al. Prevalence of human papillomavirus and Epstein-Barr virus in salivary gland diseases. J Int Med Res. 2014;42:1093–1101.
- Atula T, Grenman R, Klemi P, et al. Human papillomavirus, Epstein-Barr virus, human herpesvirus 8 and human cytomegalovirus involvement in salivary gland tumours. Oral Oncol. 1998;34:391–395.
- Skalova A, Kaspirkova J, Andrle P, et al. Human papillomaviruses are not involved in the etiopathogenesis of salivary gland tumors. Cesk Patol. 2013;49:72–75.
- Descamps G, Duray A, Rodriguez A, et al. Detection and quantification of human papillomavirus in benign and malignant parotid lesions. Anticancer Res. 2012;32:3929–3932.
- Miah MS, Majumdar S, White S, et al. Human papillomavirus and salivary gland neoplasia: a p16INK4 immunohistochemical and in situ hybridisation study. J Laryngol Otol. 2015;129:1000–1003.
- Haeggblom L, Ursu RG, Mirzaie L, et al. No evidence for human papillomavirus having a causal role in salivary gland tumors. Diagn Pathol. 2018;13:44.
- Nomura F, Sugimoto T, Kitagaki K, et al. Clinical characteristics of Japanese oropharyngeal squamous cell carcinoma positive for human papillomavirus infection. Acta Otolaryngol. 2014;134:1265–1274.
- Kato Y, Peled N, Wynes MW, et al. Novel epidermal growth factor receptor mutation-specific antibodies for non-small cell lung cancer: immunohistochemistry as a possible screening method for epidermal growth factor receptor mutations. J Thorac Oncol. 2010;5:1551–1558.
- Jalouli M, Jalouli J, Ibrahim SO, et al. Comparison between single PCR and nested PCR in detection of human papilloma viruses in paraffin-embedded OSCC and fresh oral mucosa. In Vivo (Athens, Greece) 2015;29:65–70.
- Biron VL, Kostiuk M, Isaac A, et al. Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction. Cancer 2016;122:1544–1551.
- Antonsson A, Knight L, Panizza BJ, et al. HPV-16 viral load in oropharyngeal squamous cell carcinoma using digital PCR. Acta Otolaryngol. 2018;138:1–5.
- Jalouli J, Ibrahim SO, Sapkota D, et al. Presence of human papilloma virus, herpes simplex virus and Epstein-Barr virus DNA in oral biopsies from Sudanese patients with regard to toombak use. J Oral Pathol Med. 2010;39:599–604.